You searched for "regeneration"
Esme’s Umbrella becomes first CBS charity in the world
Esme’s Umbrella – the Campaign to raise awareness of Charles Bonnet Syndrome (CBS) – has been given charity status by the England and Wales Charity Commission.The Eye Care Support Pathway from RNIB
The #EyeCareSupportPathway is a framework, developed by RNIB and partners across the sector, for the NHS, social care organisations, the third sector and the public to use to support the transformation of eye care and eye services.SightCare announces Leadership transition as Martin Smith steps down as Chair
SightCare, the trusted partner to independent optical practices in the UK, announces that Martin Smith has stepped down as Chair and that Vice Chair, Garrey Haase succeeds him with immediate effect. Martin has served as Chair with dedication, providing reliable...How to be ‘appy’ on call: a brief guide to mobile phone applications for the on-call ophthalmologist
One of the unexpected outcomes of the COVID-19 pandemic has been an increased reliance and integration of computer technology within hospital medicine. The need for stricter infection control policies during and after lockdown has seen a boom in technology utilisation....
Treat-and-extend regimen in treatment of patients with type 3 neovascularisation
Type 3 neovascularisation, also known as retinal angiomatous proliferation is a distinct subtype of neovascular AMD characterised by intraretinal neovascularisation. This retrospective study included 17 eyes diagnosed with type 3 neovascularisation who were changed from pro-re-nata (PRN) based treatment regime...
IR recession and prevention of lower lid retraction
The authors report the efficacy in preventing lower eyelid retraction and long-term results of a new technique of inferior rectus recession for vertical strabismus. The results for 35 patients were compared with 22 patients having conventional inferior rectus recession. Inferior...
Episcleral brachytherapy (EB) for retinoblastoma (RB)
This retrospective study consisted of 11 eyes treated either with Iodine (I) -125 or Ruthenium (R) -106EB with a mean apical dose of 44Gy. There were five in group B (46%), three in group C (27%) and three in group...
